Skip to main content
Journal cover image

Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.

Publication ,  Journal Article
Hansen, JW; Foy, A; Yadav, P; Gilchrist, IC; Kozak, M; Stebbins, A; Matsouaka, R; Vemulapalli, S; Wang, A; Wang, DD; Eng, MH; Greenbaum, AB ...
Published in: JACC Cardiovasc Interv
October 23, 2017

OBJECTIVES: The authors sought to elucidate the true incidence of renal replacement therapy (RRT) after transcatheter aortic valve replacement (TAVR). BACKGROUND: There is a wide discrepancy in the reported rate of RRT after TAVR (1.4% to 40%). The true incidence of RRT after TAVR is unknown. METHODS: The STS/ACC TVT (Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy) registry was linked to the Centers for Medicare & Medicaid database to identify all patients that underwent TAVR from November 2011 through September 2015 and their outcomes. The authors compared rates of death, new RRT, and a composite of both as a function of pre-procedure glomerular filtration rate (GFR), both in stages of chronic kidney disease (CKD), as well as on a continuous scale. RESULTS: Pre-procedure GFR is associated with the risk of death and new RRT after TAVR when GFR is <60 ml/min/m2, and increases significantly when GFR falls below 30 ml/min/m2. Incremental increases in GFR of 5 ml/min/m2 were statistically significant (unadjusted hazard ratio: 0.71; p < 0.001) at 30 days, and continued to be significant at 1 year when pre-procedure GFR was <60 ml/min/m2. One in 3 CKD stage 4 patients will be dead within 1 year, with 14.6% (roughly 1 in 6) requiring dialysis. In CKD stage 5, more than one-third of patients will require RRT within 30 days; nearly two-thirds will require RRT at 1 year. CONCLUSIONS: In both unadjusted and adjusted analysis, pre-procedural GFR was associated with the outcomes of death and new RRT. Increasing CKD stage leads to an increased risk of death and/or RRT. Continuous analysis showed significant differences in outcomes in all levels of CKD when GFR was <60 ml/min/m2. Pre-procedure GFR should be considered when selecting CKD patients for TAVR.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

October 23, 2017

Volume

10

Issue

20

Start / End Page

2064 / 2075

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Time Factors
  • Risk Factors
  • Retrospective Studies
  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Registries
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hansen, J. W., Foy, A., Yadav, P., Gilchrist, I. C., Kozak, M., Stebbins, A., … O’Neill, W. O. (2017). Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. JACC Cardiovasc Interv, 10(20), 2064–2075. https://doi.org/10.1016/j.jcin.2017.09.001
Hansen, James W., Andrew Foy, Pradeep Yadav, Ian C. Gilchrist, Mark Kozak, Amanda Stebbins, Roland Matsouaka, et al. “Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.JACC Cardiovasc Interv 10, no. 20 (October 23, 2017): 2064–75. https://doi.org/10.1016/j.jcin.2017.09.001.
Hansen JW, Foy A, Yadav P, Gilchrist IC, Kozak M, Stebbins A, et al. Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2017 Oct 23;10(20):2064–75.
Hansen, James W., et al. “Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.JACC Cardiovasc Interv, vol. 10, no. 20, Oct. 2017, pp. 2064–75. Pubmed, doi:10.1016/j.jcin.2017.09.001.
Hansen JW, Foy A, Yadav P, Gilchrist IC, Kozak M, Stebbins A, Matsouaka R, Vemulapalli S, Wang A, Wang DD, Eng MH, Greenbaum AB, O’Neill WO. Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2017 Oct 23;10(20):2064–2075.
Journal cover image

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

October 23, 2017

Volume

10

Issue

20

Start / End Page

2064 / 2075

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Time Factors
  • Risk Factors
  • Retrospective Studies
  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Registries
  • Male